May 2021

|
Volume 33 Issue 5 E
To learn more about the comparative effectiveness and safety of contemporary TAVI devices, we queried data from the national Italian TAVI registry comparing features, procedural details, and 12-month outcomes of Acurate Neo, Evolut Pro/R, Lotus, Port…
Instant feedback about the actual radiation dose received may help operators optimize the use of existing shielding devices. The current study was designed to investigate whether routine use of real-time dosimetry may be able to reduce staff radiatio…
The study by Murat demonstrates that positive feedback in real-time helps operators reduce exposure.
The new Sapien 3 Ultra valve was designed to improve paravalvular sealing. We assess its performance in patients with an annulus size in proximity to the prosthesis size.
Evidence to support anatomical imaging is growing, with CCTA gaining attention as the more accurate non-invasive testing modality. We review current literature and formulate a direction for CCTA-based future research.
We compared procedural and clinical outcome variables of the Sapien 3 balloon-expandable valve and the Evolut R/Pro self-expanding valve in an all-comers collective.
Few data are available on the safety of interventions for peripheral arterial disease performed in the office-based laboratory (OBL) setting. Thus, the aim of this study was to investigate the short- and late-term outcomes of patients treated in OBL…
Despite increasing use of VA-ECMO in patients with CS secondary to STEMI, a paucity of adequate evidence for this therapy remains. The aim of this single-center clinical registry study was to identify predictors of survival and discern the possible o…
The objective of this study was to assess procedural outcomes of balloon pulmonary artery angioplasty procedures after complete repair of tetralogy of Fallot with major aortopulmonary collateral arteries.
This study assesses whether combining venoarterial extracorporeal membrane oxygenation (VA-ECMO) with intra-aortic balloon pump (IABP) improves outcomes in ST-segment elevation myocardial infarction (STEMI) over VA-ECMO alone.